Table II.
Characteristics | Mean ± standard deviation (range) | n (%) |
---|---|---|
Sex | ||
Male | 67 (67.0) | |
Female | 33 (33.0) | |
Age, years | 61.6±11.1 (31–84) | |
Duration of CLL, months | 55.8±34.8 (1–144) | |
WBC, count/mm3 | 43.8±42.5 (2–236) | |
Platelet, count/mm3 | 173.5±69.9 (60–477) | |
Hb, g/dl | 12.5±2.1 (7–17) | |
LDH, IU/l | 383.3±152.9 (50–980) | |
Stage | ||
0 | 25 (29.1) | |
I | 15 (17.4) | |
II | 8 (9.3) | |
III | 21 (24.4) | |
IV | 17 (19.8) |
CLL, chronic lymphocytic leukemia; WBC, white blood cells; Hb, hemoglobin; LDH, lactate dehydrogenase.